[TSH-secreting pituitary adenoma: 16 years follow-up].
Koch
C A
CA
National Institutes of Health (NIH), NICHD, Bethesda, MD, USA. Kochc@exchange.nih.gov
Skarulis
M C
MC
Patronas
N J
NJ
Sarlis
N J
NJ
D000236:Adenoma / Q000378:metabolism* / Q000628:therapy; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007016:Hypophysectomy; D008297:Male; D018365:Neoplasm, Residual / Q000188:drug therapy / Q000601:surgery; D015282:Octreotide / Q000627:therapeutic use; D010907:Pituitary Hormones / Q000097:blood; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000628:therapy; D013972:Thyrotropin / Q000096:biosynthesis* / Q000097:blood; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D010907:Pituitary Hormones; D013972:Thyrotropin; D015282:Octreotide